Cristina Ruisanchez

Cristina Ruisanchez

Auto-generated profile, based on publicly available information

Cristina Ruisanchez

Section Chief of Cardiac Imaging, Hospital Universitario Marques de Valdecilla, Santander, Spain

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2007 in Revista Espanola de Cardiologia
Verified
Journal Article
Closed access
JHJosé M. de la Torre Hernández
José M. de la Torre Hernández
MRMarta Ruiz-Lera
Marta Ruiz-Lera
LFLeticia Fernández-Friera
Leticia Fernández-Friera
CRCristina Ruisanchez
Cristina Ruisanchez
FSFermín Sainz-Laso
Fermín Sainz-Laso
TCThierry Colman
Thierry Colman

9 February 2017 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
CRCristina Ruisanchez
Cristina Ruisanchez
JSJ. Aurelio Sarralde
J. Aurelio Sarralde
CGCamilo Gonzalez-Fernandez
Camilo Gonzalez-Fernandez
MDM. Jose Dominguez
M. Jose Dominguez

27 February 2021 in Echocardiography
Verified
Journal Article
Closed access
PDF file
CVCristina Ruisanchez Villar
Cristina Ruisanchez Villar
SLSofia Gonzalez Lizarbe
Sofia Gonzalez Lizarbe
PSPiedad Lerena Saenz
Piedad Lerena Saenz
AOAritz Gil Ongay
Aritz Gil Ongay
TVTeresa Borderias Villarroel
Teresa Borderias Villarroel
JCJose Maria Cuesta Cosgaya
Jose Maria Cuesta Cosgaya

12 April 2017 in Echocardiography
Verified
Journal Article
Closed access
PDF file
CRCristina Ruisanchez
Cristina Ruisanchez
AAAngela Alonso
Angela Alonso
BCBeatriz Carballo
Beatriz Carballo
AGAritz Gil
Aritz Gil
PLPiedad Lerena
Piedad Lerena
FRFrancisco Javier Ruano
Francisco Javier Ruano

1 September 2023 in REC: Interventional Cardiology (English Edition)
Verified
Journal Article
Open access
SLSofía González Lizarbe
Sofía González Lizarbe
TVTeresa Borderías Villarroel
Teresa Borderías Villarroel
CVCristina Ruisánchez Villar
Cristina Ruisánchez Villar
JMJosé María Navasa Melado
José María Navasa Melado
IPIvana Pulitani
Ivana Pulitani
DHDae-Hyun Lee Hwang
Dae-Hyun Lee Hwang
Revista Española de Cardiología: Interventional Cardiology

31 December 2025 in Heart
Verified
Journal Article
Closed access
ECElton Carreiro Da Cunha
Elton Carreiro Da Cunha
IOItziar Cucurull Ortega
Itziar Cucurull Ortega
MSMiriam Rodríguez de Rivera Socorro
Miriam Rodríguez de Rivera Socorro
LPLucía Muñoz Prejigueiro
Lucía Muñoz Prejigueiro
LSLucía Abia Sarriá
Lucía Abia Sarriá
CVCristina Ruisanchez Villar
Cristina Ruisanchez Villar
Background: Exercise stress echocardiography (ESE) is widely used to detect inducible myocardial ischaemia. However, a substantial proportion of ESEs remains inconclusive or shows abnormal non-ischaemic findings (fixed regional wall motion abnormalities without new inducible ischaemia), often requiring further testing. Baseline characteristics differ markedly between these groups, highlighting the need for studies that precisely adjust for confounders. This article aims to assess long-term outcomes among patients with negative, non-diagnostic or abnormal non-ischaemic ESE using robust confounder adjusted analyses. Methods: This was a retrospective cohort study conducted between 2017 and 2023 at a tertiary care hospital in Santander, northern Spain. Patients with inducible ischaemia or non-treadmill protocols were excluded. Participants were classified as diagnostic negative (≥85% predicted heart rate), non-diagnostic negative (<85%) or abnormal non-ischaemic (fixed wall motion abnormalities without inducible ischaemia). The primary endpoint was a composite of all-cause mortality, cardiovascular death, ischaemic hospitalisation and coronary angiography. Inverse probability of treatment weighting (IPTW) and generalised pairwise comparisons (GPC) assessed outcomes. Results: During a mean follow-up of 71 months among 788 patients, the overall event rate was 3.2 per 100 patient-years. Adjusted Cox models showed no significant differences between non-diagnostic (HR 0.92; 95% CI 0.49 to 1.72) or abnormal non-ischaemic (HR 0.80; 95% CI 0.24 to 2.61) versus diagnostic negative groups. Independent risk predictors included type 2 diabetes mellitus (HR 2.13; 95% CI 1.13 to 4.03) and lower ejection fraction (HR 0.97 per 1% increase; 95% CI 0.94 to 0.99). GPC identified more angiographies in the negative non-diagnostic group (p=0.04) and greater mortality in the abnormal non-ischaemic group (p=0.02) than in diagnostic negative patients, despite similar composite outcomes. Conclusion: Negative ESE generally predicts low risk; however, non-diagnostic or abnormal non-ischaemic GPC findings show subtle prognostic differences undetected by conventional analysis. These subgroups may warrant closer follow-up or additional imaging.